David Dworaczyk

David Dworaczyk, Ph.D., is an accomplished industry advisor and corporate consultant with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as an Industry Advisor for Bain Advisory Network and Silverwood Partners, and as a member of the Board of Directors at LumaBridge and Catalyst Clinical Research, Dworaczyk has held various strategic leadership roles, including CEO and Board Member at Bryn Pharma and COO at Comprehensive Clinical Development. With a focus on business strategy development, operational efficiency, and corporate turnaround strategies, Dworaczyk leverages a robust educational background, including a Ph.D. in Leadership and Business Administration from the University of Delaware, to support organizations and investors in navigating the complexities of the healthcare landscape. Additionally, Dworaczyk has contributed as an Editorial Board Member for Pharmaceutical Breakthroughs and as an educator within the Gerson Lehrman Group, providing valuable insights into the evolving dynamics of the industry.